Biomunex Pharmaceuticals signs first partnership agreement to develop bi and multispecific antibodies using its platform with sanofi httpow.lyRl3130nk0eHÂ
Biomunex Pharmaceuticals signs first partnership agreement to develop bi- and multi-specific antibodies using its platform with @sanofi: http://ow.ly/Rl3130nk0eH
More From BioPortfolio on "Biomunex Pharmaceuticals signs first partnership agreement to develop bi- and multi-specific antibodies using its platform with @sanofi: http://ow.ly/Rl3130nk0eH "